Related Experiment Video
Updated: Jun 19, 2026
12:10
Retzius-Sparing Robot-Assisted Radical Prostatectomy
Published on: May 19, 2022
Radical prostatectomy for high-risk prostate cancer
R Jeffrey Karnes1, Tadashi Hatano, Michael L Blute
1Department of Urology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.
Japanese Journal of Clinical Oncology
|October 21, 2009
Summary
Radical prostatectomy is a key treatment for high-risk prostate cancer (PC). This approach offers durable control, survival benefits, and accurate staging for operable patients with advanced disease.
Area of Science:
- Urology
- Oncology
Background:
- The prostate-specific antigen (PSA) era has shifted prostate cancer presentation towards lower-stage, lower-risk disease.
- However, high-risk prostate cancer (PC) still occurs, with less clear outcomes post-PSA introduction.
Purpose of the Study:
- To review the benefits of radical prostatectomy for high-risk prostate cancer (PC).
- To emphasize RRP as a primary treatment option for operable men with high-risk PC.
Main Methods:
- This is a review article, synthesizing existing literature on radical prostatectomy for high-risk PC.
- Focuses on cases with Gleason score 8-10, elevated PSA, and advanced clinical T stage.
Main Results:
- Radical retropubic prostatectomy (RRP) provides durable local control for high-risk PC.
- RRP offers long-term cancer-specific survival and accurate pathologic staging.
- Pathologic staging from RRP can guide subsequent individualized treatment strategies.
Conclusions:
- Radical retropubic prostatectomy (RRP) is the optimal single treatment for operable patients with high-risk prostate cancer (PC).
- RRP ensures robust local disease management and survival outcomes in this patient group.
